Astrana Health Inc. Common Stock (ASTH) Stock Price
ASTHStock
$36.81+15.79%52W
Market Cap$1.83B
P/E81.20x
PEG Ratio—
Div yield—
Beta1.24
ASTH Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)16.72%
Price vs S&P 500 (4W)11.04%
VGM Score56.15
P/E Ratio (Annual)81.20x
ASTH Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.73 | $0.80 | +9.59%(+$0.07) | |
| Q1 2026 | $0.65 | $0.74 | +13.85%(+$0.09) | |
| Q4 2025 | $0.33 | $0.42 | +28.58%(+$0.09) | |
| Q3 2025 | $0.61 | $0.67 | +10.65%(+$0.06) | |
| Q2 2025 | $0.48 | $0.58 | +21.10%(+$0.10) |
ASTH Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.29
4.29
4.29
4.25
Industry Peers — Management Consulting(39)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|---|---|---|
ASTHAstrana Health Inc. Common Stock | C | B | C | 81.2x | 5.1% | 35.9% | — | $36.81 |
| GIBCGI Inc. | B | C | B | 13.1x | 17.2% | 5.5% | 0.7% | $75.30 |
| BAHBooz Allen Hamilton Holding Corporation | B | D | C | 10.5x | 71.9% | 7.4% | 1.5% | $74.26 |
| GGENPACT LIMITED | B | C | B | 11.3x | 22.9% | 6.5% | 1.6% | $37.26 |
| FCNFTI Consulting, Inc. | B | D | C | 15.1x | 15.6% | 9.0% | — | $148.53 |
| EXPOExponent Inc | D | C | B | 32.2x | 27.9% | 7.8% | 1.3% | $71.85 |
| HURNHuron Consulting Group Inc. | C | B | A | 26.5x | 25.5% | 14.3% | — | $174.86 |
| ICFIICF International, Inc. | B | D | B | 17.5x | 8.6% | 4.4% | 0.4% | $89.43 |
| BWMNBowman Consulting Group Ltd. Common Stock | D | B | B | 57.7x | 2.9% | 32.1% | — | $42.77 |
| ROMARoma Green Finance Limited Class A Ordinary Shares | F | B | B | — | -67.9% | — | — | $8.34 |
| ONTOnterris, Inc. | C | C | C | — | -2.5% | 20.4% | — | $14.01 |
About Astrana Health Inc. Common Stock
Astrana Health is an integrated population health management company that coordinates outcomes-based medical care for seniors and patients with multiple chronic conditions. The company operates through three segments—Care Partners, Care Delivery, and Care Enablement—with Care Partners generating the majority of revenue. It combines physician-led care delivery with population health management and care coordination to improve patient outcomes while reducing costs.